Similar Molecular Origins for Certain Breast and Ovarian Cancers
A hard-to-treat form of breast cancer sometimes called “triple negative” is more like certain kinds of ovarian and lung cancers than like other breast cancers, and so doctors may be able to treat it with drugs known to work in tumors in these different tissues, suggests the latest report from the Cancer Genome Atlas.
Much of what genomics is teaching us about cancer is that every cancer type and even every tumor is different at the genetic and molecular level (not to mention that different parts of a tumor can have molecular changes not found throughout). But researchers are also finding that tumors from different parts of the body can be more alike than tumors found in the same organ, as was shown in Sunday’s report in Nature.
As Christopher Benz, an oncologist at the University of California San Francisco, told the San Francisco Chronicle:
“We’re going to move farther and farther from the practice of classifying cancers by where they arise and more and more by what their molecular composition and wiring is all about.”
Keep Reading
Most Popular
The inside story of how ChatGPT was built from the people who made it
Exclusive conversations that take us behind the scenes of a cultural phenomenon.
How Rust went from a side project to the world’s most-loved programming language
For decades, coders wrote critical systems in C and C++. Now they turn to Rust.
Design thinking was supposed to fix the world. Where did it go wrong?
An approach that promised to democratize design may have done the opposite.
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.